癌症生物学与医学（英文版）2025，Vol.22Issue(6)：639-643,5.DOI:10.20892/j.issn.2095-3941.2025.0072
Malignant ascites enhance γδ T cell cytotoxicity toward ovarian cancer via chemokine-mediated recruitment
Malignant ascites enhance γδ T cell cytotoxicity toward ovarian cancer via chemokine-mediated recruitment
Zhanqun Yang 1Jian Lin 2Long Chen 1Ying Liu 3Mengzhu Zheng 4Hui Li 1Ruoyao Cui 3Pan Wang 5Tianhui He 5Hongyan Guo 5Yinglin Zhou3
作者信息
- 1. Department of Pharmacy,Peking University Third Hospital Cancer Center,Peking University Third Hospital,Beijing 100191,China
- 2. Department of Pharmacy,Peking University Third Hospital Cancer Center,Peking University Third Hospital,Beijing 100191,China||Key Laboratory of Tropical Biological Resources of Ministry of Education,Song Li's Academician Workstation of Hainan University,School of Pharmaceutical Sciences,Hainan University,Haikou 572000,China||Synthetic and Functional Biomolecules Center,Peking University,Beijing 100871,China||College of Life Science,Anhui Medical University,Hefei 230032,China
- 3. Beijing National Laboratory for Molecular Sciences(BNLMS),Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education,College of Chemistry and Molecular Engineering,Peking University,Beijing 100871,China
- 4. Key Laboratory of Tropical Biological Resources of Ministry of Education,Song Li's Academician Workstation of Hainan University,School of Pharmaceutical Sciences,Hainan University,Haikou 572000,China
- 5. Department of Obstetrics and Gynecology,Peking University Third Hospital,Beijing 100191,China
- 折叠
引用本文复制引用
Zhanqun Yang,Jian Lin,Long Chen,Ying Liu,Mengzhu Zheng,Hui Li,Ruoyao Cui,Pan Wang,Tianhui He,Hongyan Guo,Yinglin Zhou..Malignant ascites enhance γδ T cell cytotoxicity toward ovarian cancer via chemokine-mediated recruitment[J].癌症生物学与医学（英文版）,2025,22(6):639-643,5.基金项目
This work was supported by the National Natural Science Foundation of China(Grant No.82274034)and the Peking University Medicine plus X Pilot Program-Platform Construction Project(Grant No.2024YXXLHPT004). （Grant No.82274034）
